Reversing Fatty Liver Disease: NAFLD and NASH Treatment Options

Jump To Section

• NAFLD Reversibility
• Liver Fat Clearance
• NASH Regression Evidence
• Bariatric Surgery Impact
• Pharmacologic Therapies
• Future Treatment Goals
• Full Transcript

NAFLD Reversibility

Dr. Scott Friedman, MD, confirms that nonalcoholic fatty liver disease is absolutely reversible. He explains that liver fat can wax and wane depending on body mass index and environmental factors. This reversibility offers hope for patients diagnosed with this common liver condition.

Liver Fat Clearance

Fat in the liver can be cleared relatively quickly according to Dr. Friedman. The speed of clearance depends on various metabolic factors and lifestyle changes. This rapid clearance potential makes early intervention particularly valuable for patients.

NASH Regression Evidence

Dr. Scott Friedman, MD, presents evidence that inflammation and fibrosis associated with NASH may also be reversible. This represents a significant advancement in understanding progressive liver disease. The potential for regression of more advanced disease stages changes treatment paradigms.

Bariatric Surgery Impact

The best current data for NASH reversal comes from bariatric surgery outcomes. Dr. Friedman references important publications documenting regression in patients who undergo weight loss surgery. Significant weight loss appears to be a critical factor in achieving liver disease regression.

Pharmacologic Therapies

Dr. Scott Friedman, MD, notes that no pharmacologic therapy has yet been approved for convincing reduction of fat, inflammation, and scarring. NAFLD and NASH remain the most intense areas of focus in drug development. The interview with Dr. Anton Titov, MD, highlights the urgent need for effective medications.

Future Treatment Goals

The ultimate goal is developing medications that reduce inflammation and liver scarring, not just liver fat. Dr. Scott Friedman, MD, emphasizes this comprehensive approach to treatment. Dr. Anton Titov, MD, facilitates this discussion about future therapeutic targets for fatty liver disease patients.

Full Transcript

Dr. Anton Titov, MD: Is fatty liver disease, NAFLD, reversible? What are the conditions for reversibility of NAFLD and NASH?

Dr. Scott Friedman, MD: Also, a very important question. Yes, NAFLD is absolutely reversible. In fact, fat in the liver can wax and wane depending on the body mass index and perhaps environmental factors.

We know liver fat can be cleared from the liver relatively quickly. For sure, that part is reversible. There's even evidence that under certain circumstances, the inflammation and fibrosis associated with NASH may also be reversible.

The best data currently comes from the results of bariatric surgery in large groups of patients. There have been a number of important publications that document that the liver fat and NASH can regress in patients who undergo bariatric surgery, particularly if they lose quite a bit of weight.

Dr. Anton Titov, MD: What we don't have yet is a pharmacologic therapy that has been approved that can convincingly reduce both fat and inflammation, and scarring.

Dr. Scott Friedman, MD: NAFLD and NASH remain the most intense areas of focus in the drug development space. We need to get a medication approved that will reduce the amount of inflammation and liver scarring and not just the amount of liver fat.